Fabien Tillier

Can we discover pharmacological promiscuity early in the drug discovery process?

Wolfgang Guba, Jérôme Hert, Alexander Hillebrecht, 2012, Drug discovery today.

The determination of epigenetic target specificity and identification of epigenetics-related in vivo adverse drug reactions

Boryeu Mao, J. Migeon, A. Otto-Bruc, 2013 .

Safety screening in early drug discovery: An optimized assay panel.

Wolfgang Guba, Christian Kramer, Manfred Kansy, 2019, Journal of pharmacological and toxicological methods.